XTX Topco
ABEO icon

XTX Topco’s Abeona Therapeutics ABEO Stock Holding History

XTX Topco’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69,120
Closed -$310K – 4093
2026
Q1 		$310K Buy
69,120
+19,782
+40% +$98.9K 0.01% 2457
2025
Q4 		$260K Buy
49,338
+9,979
+25% +$50.2K 0.01% 2194
2025
Q3 		$208K Buy
+39,359
New +$250K 0.01% 1817
2024
Q4 		– Sell
-25,301
Closed -$160K – 2220
2024
Q3 		$160K Buy
+25,301
New +$132K 0.01% 1509
2023
Q1 		– Sell
-51,888
Closed -$160K – 1223
2022
Q4 		$160K Buy
+51,888
New +$194K 0.03% 909
2021
Q3 		– Sell
-3,078
Closed -$120K – 652
2021
Q2 		$120K Buy
+3,078
New +$126K 0.04% 638

Other funds holding ABEO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cable Car Capital
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OneDigital Investment Advisors
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

XTX Topco's ABEO Position: Q2 2026 in Review

XTX Topco sold out of Abeona Therapeutics (ABEO) in Q2 2026, closing a stake of 69,120 shares — an estimated $310K sold.

XTX Topco first reported a position in ABEO in Q2 2021 and held it in 6 quarters. The position peaked at $310K in Q1 2026. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • XTX Topco reported no remaining Abeona Therapeutics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 69,120 Abeona Therapeutics shares in Q2 2026, an estimated $310K.
  • XTX Topco first reported a position in Abeona Therapeutics in Q2 2021 and held it in 6 quarters.
  • XTX Topco's Abeona Therapeutics position peaked at $310K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.